Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors

BACKGROUND: This study examined the prevalence of hypogonadism, its clinical and genetic risk factors, and its relationship to adverse health outcomes (AHOs) in North American testicular cancer survivors (TCS) after modern platinum-based chemotherapy. PATIENTS AND METHODS: Eligible TCS were <55 y...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Natl Compr Canc Netw
Autori principali: Abu Zaid, Mohammad, Dinh, Paul C., Monahan, Patrick O., Fung, Chunkit, El-Charif, Omar, Feldman, Darren R., Hamilton, Robert J., Vaughn, David J., Beard, Clair J., Cook, Ryan, Althouse, Sandra, Ardeshir-Rouhani-Fard, Shirin, Sesso, Howard D., Huddart, Robert, Mushiroda, Taisei, Kubo, Michiaki, Eileen Dolan, M., Einhorn, Lawrence H., Fossa, Sophie D., Travis, Lois B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6712564/
https://ncbi.nlm.nih.gov/pubmed/31085753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jnccn.2018.7109
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi